Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Blood tests confirmed a baby in the womb had a CMV infection.

Two patients with porphyria cutanea tarda experienced their grey hair turning dark again.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

PNKP is essential for keeping adult mouse progenitor cells healthy and growing normally.

The effects of estrogen on human scalp hair growth are unclear and need more research.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

Tamoxifen effectively treats gynecomastia without causing impotence.

Active vitamin D3 might protect hair follicles from radiation damage.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.